2001

Nov 9, 2001
Guidant and Cook Announce FDA Approval To Begin U.S. Clinical Trial With Paclitaxel-Coated Stent

First U.S. Patient Treated in Pivotal Clinical Trial Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) and Cook Incorporated today announced Investigational Device Exemption (IDE)...

Nov 8, 2001
Guidant to Host Vascular Intervention Investor Briefing at AHA

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host an...

Nov 7, 2001
Guidant and Merck KGaA Collaborate on Heart Failure Education

International Symposium Offers Unique Opportunity for Experts in Device Technology and Drug Therapy to Share Knowledge Indianapolis, IN - A major international heart failure symposium co-sponsored...

Nov 6, 2001
Guidant Announces First Human Implant of Newest Active-Fixation Defibrillation Lead

Defibrillation Lead Features Advances in Handling and Visibility for Ease in Positioning Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Nov 5, 2001
Guidant's Automated Radiotherapy Treatment for Coronary Artery Disease Receives FDA Approval

GALILEO System Sets New Standards of Precision and Ease of Use Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary...

Oct 18, 2001
Guidant Reports Record Third Quarter Sales of $662 Million

Double Digit Growth from Balanced Geographic Performance; Earnings Per Share Reach $0.40 Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for the treatment...

Oct 15, 2001
Guidant Announces Live Webcast of Annual Analyst Meetin

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host its annual analyst meeting...

Oct 12, 2001
Guidant Launches Carotid Stent System in Europe

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, today announced that the company has...

Oct 11, 2001
Guidant Announces Live Webcast of its Third Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, will conduct a live webcast of its third quarter 2001 earnings...

Oct 10, 2001
Guidant Announces Worldwide Launch of New Product for Treating Peripheral Vascular Disease

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced the global launch of its second-generation VIATRAC(tm) 14 PLUS Peripheral Dilatation Catheter...

Show per page

Top